|Bid||318.64 x 800|
|Ask||319.00 x 1400|
|Day's range||316.13 - 321.75|
|52-week range||275.89 - 475.35|
|Beta (5Y monthly)||1.15|
|PE ratio (TTM)||35.56|
|Earnings date||26 Oct 2022 - 31 Oct 2022|
|Forward dividend & yield||0.72 (0.22%)|
|Ex-dividend date||19 Jul 2022|
|1y target est||383.17|
West Pharmaceutical's (WST) minority investment is expected to aid in meeting patients' continuously evolving needs of ease of use and effective methods of medicine delivery.
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
This morning, Eric Green and Bernard Birkett will review our financial results, provide an update on our business and present an update on our financial outlook for the remaining full year of 2022. There is a slide presentation that accompanies today's call and a copy of that presentation is available on the Investors section of our website.